These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34964311)

  • 1. Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.
    Pose E; Solà E; Lozano JJ; Juanola A; Sidorova J; Zaccherini G; de Wit K; Uschner F; Tonon M; Kazankov K; Jiménez C; Campion D; Napoleone L; Ma AT; Carol M; Morales-Ruiz M; Alessandria C; Beuers U; Caraceni P; Francoz C; Durand F; Mookerjee RP; Trebicka J; Vargas V; Piano S; Watson H; Abraldes JG; Kamath PS; Davis MM; Ginès P;
    Hepatol Commun; 2022 May; 6(5):1100-1112. PubMed ID: 34964311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Pose E; Napoleone L; Amin A; Campion D; Jimenez C; Piano S; Roux O; Uschner FE; de Wit K; Zaccherini G; Alessandria C; Angeli P; Bernardi M; Beuers U; Caraceni P; Durand F; Mookerjee RP; Trebicka J; Vargas V; Andrade RJ; Carol M; Pich J; Ferrero J; Domenech G; Llopis M; Torres F; Kamath PS; Abraldes JG; Solà E; Ginès P
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):31-41. PubMed ID: 31607677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
    Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
    Moreau R; Clària J; Aguilar F; Fenaille F; Lozano JJ; Junot C; Colsch B; Caraceni P; Trebicka J; Pavesi M; Alessandria C; Nevens F; Saliba F; Welzel TM; Albillos A; Gustot T; Fernández J; Moreno C; Baldassarre M; Zaccherini G; Piano S; Montagnese S; Vargas V; Genescà J; Solà E; Bernal W; Butin N; Hautbergue T; Cholet S; Castelli F; Jansen C; Steib C; Campion D; Mookerjee R; Rodríguez-Gandía M; Soriano G; Durand F; Benten D; Bañares R; Stauber RE; Gronbaek H; Coenraad MJ; Ginès P; Gerbes A; Jalan R; Bernardi M; Arroyo V; Angeli P; ; ;
    J Hepatol; 2020 Apr; 72(4):688-701. PubMed ID: 31778751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis.
    López-Vicario C; Checa A; Urdangarin A; Aguilar F; Alcaraz-Quiles J; Caraceni P; Amorós A; Pavesi M; Gómez-Cabrero D; Trebicka J; Oettl K; Moreau R; Planell N; Arroyo V; Wheelock CE; Clària J
    J Hepatol; 2020 Oct; 73(4):817-828. PubMed ID: 32294533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.
    Clària J; Moreau R; Fenaille F; Amorós A; Junot C; Gronbaek H; Coenraad MJ; Pruvost A; Ghettas A; Chu-Van E; López-Vicario C; Oettl K; Caraceni P; Alessandria C; Trebicka J; Pavesi M; Deulofeu C; Albillos A; Gustot T; Welzel TM; Fernández J; Stauber RE; Saliba F; Butin N; Colsch B; Moreno C; Durand F; Nevens F; Bañares R; Benten D; Ginès P; Gerbes A; Jalan R; Angeli P; Bernardi M; Arroyo V;
    Hepatology; 2019 Apr; 69(4):1686-1701. PubMed ID: 30521097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).
    Weiss E; de la Peña-Ramirez C; Aguilar F; Lozano JJ; Sánchez-Garrido C; Sierra P; Martin PI; Diaz JM; Fenaille F; Castelli FA; Gustot T; Laleman W; Albillos A; Alessandria C; Domenicali M; Caraceni P; Piano S; Saliba F; Zeuzem S; Gerbes AL; Wendon JA; Jansen C; Gu W; Papp M; Mookerjee R; Gambino CG; Jiménez C; Giovo I; Zaccherini G; Merli M; Putignano A; Uschner FE; Berg T; Bruns T; Trautwein C; Zipprich A; Bañares R; Presa J; Genesca J; Vargas V; Fernández J; Bernardi M; Angeli P; Jalan R; Claria J; Junot C; Moreau R; Trebicka J; Arroyo V
    Gut; 2023 Aug; 72(8):1581-1591. PubMed ID: 36788015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure.
    Zhang IW; Curto A; López-Vicario C; Casulleras M; Duran-Güell M; Flores-Costa R; Colsch B; Aguilar F; Aransay AM; Lozano JJ; Hernández-Tejero M; Toapanta D; Fernández J; Arroyo V; Clària J
    J Hepatol; 2022 Jan; 76(1):93-106. PubMed ID: 34450236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifaximin treatment shapes a unique metagenome-metabolism network in patients with decompensated cirrhosis.
    Nie MT; Wang PQ; Shi PM; Hong XL; Zhang X; Xiang B; Zhang M; Xie WF
    J Gastroenterol Hepatol; 2024 Apr; 39(4):762-771. PubMed ID: 38233085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
    Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
    J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
    J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
    Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
    J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
    Trebicka J; Amoros A; Pitarch C; Titos E; Alcaraz-Quiles J; Schierwagen R; Deulofeu C; Fernandez-Gomez J; Piano S; Caraceni P; Oettl K; Sola E; Laleman W; McNaughtan J; Mookerjee RP; Coenraad MJ; Welzel T; Steib C; Garcia R; Gustot T; Rodriguez Gandia MA; Bañares R; Albillos A; Zeuzem S; Vargas V; Saliba F; Nevens F; Alessandria C; de Gottardi A; Zoller H; Ginès P; Sauerbruch T; Gerbes A; Stauber RE; Bernardi M; Angeli P; Pavesi M; Moreau R; Clària J; Jalan R; Arroyo V
    Front Immunol; 2019; 10():476. PubMed ID: 30941129
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial.
    Kimer N; Pedersen JS; Busk TM; Gluud LL; Hobolth L; Krag A; Møller S; Bendtsen F;
    Hepatology; 2017 Feb; 65(2):592-603. PubMed ID: 27775818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.
    Clària J; Stauber RE; Coenraad MJ; Moreau R; Jalan R; Pavesi M; Amorós À; Titos E; Alcaraz-Quiles J; Oettl K; Morales-Ruiz M; Angeli P; Domenicali M; Alessandria C; Gerbes A; Wendon J; Nevens F; Trebicka J; Laleman W; Saliba F; Welzel TM; Albillos A; Gustot T; Benten D; Durand F; Ginès P; Bernardi M; Arroyo V;
    Hepatology; 2016 Oct; 64(4):1249-64. PubMed ID: 27483394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.
    Hernaez R; Kramer JR; Liu Y; Tansel A; Natarajan Y; Hussain KB; Ginès P; Solà E; Moreau R; Gerbes A; El-Serag HB; Kanwal F
    J Hepatol; 2019 Apr; 70(4):639-647. PubMed ID: 30590100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives.
    Nagel M; Labenz C; Wörns MA; Marquardt JU; Galle PR; Schattenberg JM; Nguyen-Tat M
    Health Qual Life Outcomes; 2020 Jan; 18(1):10. PubMed ID: 31931822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial.
    Kimer N; Pedersen JS; Tavenier J; Christensen JE; Busk TM; Hobolth L; Krag A; Al-Soud WA; Mortensen MS; Sørensen SJ; Møller S; Bendtsen F;
    J Gastroenterol Hepatol; 2018 Jan; 33(1):307-314. PubMed ID: 28671712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of patients with hepatitis B virus-related acute on chronic liver failure: An observational cohort study.
    Lin S; Zhang K; Zhang J; Wang M; Velani B; Zhu Y
    Liver Int; 2019 May; 39(5):854-860. PubMed ID: 30753752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.
    Markwardt D; Holdt L; Steib C; Benesic A; Bendtsen F; Bernardi M; Moreau R; Teupser D; Wendon J; Nevens F; Trebicka J; Garcia E; Pavesi M; Arroyo V; Gerbes AL
    Hepatology; 2017 Oct; 66(4):1232-1241. PubMed ID: 28545169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.